Rainmed Medical Limited (HKG:2297)
Hong Kong
· Delayed Price · Currency is HKD
0.1640
0.00 (0.00%)
May 19, 2025, 3:27 PM HKT
Rainmed Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -113.5 | -115.83 | -1,346 | -633.65 |
| Depreciation & Amortization | 22.54 | 22.24 | 16.39 | 10.81 |
| Other Amortization | - | - | 0.28 | 0.05 |
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 0.02 | 0.04 |
| Asset Writedown & Restructuring Costs | 18.76 | - | - | - |
| Loss (Gain) From Sale of Investments | -1.25 | -1.06 | -0 | -0.04 |
| Stock-Based Compensation | 0.88 | 7.48 | 13.4 | 67.17 |
| Other Operating Activities | -2.78 | -9.32 | 1,204 | 492.69 |
| Change in Accounts Receivable | -6.12 | -5.41 | -2.07 | -0.43 |
| Change in Inventory | -1.26 | -0.74 | 2.3 | -4.6 |
| Change in Accounts Payable | -14.92 | -22.94 | 9.42 | 16.29 |
| Change in Unearned Revenue | 2.37 | 0.24 | -3.24 | -16.24 |
| Change in Other Net Operating Assets | 10.97 | 1.04 | -5.74 | -4.95 |
| Operating Cash Flow | -84.31 | -124.29 | -111.22 | -72.83 |
| Capital Expenditures | -44.2 | -84.68 | -17.11 | -30.84 |
| Sale of Property, Plant & Equipment | 0.1 | 0.07 | 0.16 | 0.09 |
| Cash Acquisitions | - | -13.89 | - | - |
| Sale (Purchase) of Intangibles | -9.6 | -26.3 | -12.71 | -0.28 |
| Investment in Securities | 58.59 | 291.43 | -482.25 | 3.04 |
| Other Investing Activities | 1.42 | 9.66 | 0.17 | - |
| Investing Cash Flow | 6.31 | 180.29 | -515.74 | -27.98 |
| Long-Term Debt Issued | 20.8 | 30.57 | 18 | 270.41 |
| Long-Term Debt Repaid | -19.31 | -45.51 | -6.6 | -284.88 |
| Net Debt Issued (Repaid) | 1.49 | -14.94 | 11.4 | -14.47 |
| Issuance of Common Stock | - | - | 126.99 | 0.93 |
| Other Financing Activities | -0.77 | -0.94 | -17.66 | -9.84 |
| Financing Cash Flow | 0.72 | -15.88 | 120.73 | 633.85 |
| Foreign Exchange Rate Adjustments | -2.21 | 2.84 | 38.21 | -1.48 |
| Net Cash Flow | -79.48 | 42.97 | -468.02 | 531.55 |
| Free Cash Flow | -128.5 | -208.97 | -128.33 | -103.67 |
| Free Cash Flow Margin | -322.68% | -285.40% | -153.50% | -127.67% |
| Free Cash Flow Per Share | -0.11 | -0.18 | -0.14 | -0.16 |
| Cash Interest Paid | 0.77 | 0.94 | 0.14 | 3.17 |
| Cash Income Tax Paid | 0.26 | 0 | - | - |
| Levered Free Cash Flow | -97.67 | -183.52 | -92.47 | - |
| Unlevered Free Cash Flow | -97.08 | -182.71 | -92 | - |
| Change in Net Working Capital | 4.12 | 19.15 | 1.5 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.